Literature DB >> 16755241

Bisphosphonate-associated arthritis.

Alejandro Diaz-Borjon1, Thorsten M Seyler, Natasha L Chen, S Sam Lim.   

Abstract

We present a case of arthritis apparently induced by the administration of intravenous bisphosphonates in a 51-year-old white woman with metastatic breast carcinoma. She presented with bilateral knee pain and effusions on 2 separate occasions after receiving aminobisphosphonates. Synovial fluid analysis was negative for infection, metastasis, or crystals. Her symptoms resolved after the medication was discontinued and recurred after the patient was rechallenged with a medication from the same drug class. The administration of aminobisphosphonates has been associated with an acute-phase response in several in vivo studies. The mechanism of action is thought to be that aminobisphosphonates transiently stimulate the production of proinflammatory cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor-alpha. Rheumatologists should be aware of this possible cause of arthropathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755241     DOI: 10.1097/01.rhu.0000221796.06383.4e

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  8 in total

1.  Acute pseudogout after pamidronate infusion.

Authors:  Daniel Wendling; Guillaume Tisserand; Vincent Griffond; Clarisse Saccomani; Eric Toussirot
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

2.  An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy.

Authors:  Liron Caplan; Cory B Pittman; Angelique L Zeringue; Jeffrey F Scherrer; Kent R Wehmeier; Francesca E Cunningham; Seth A Eisen; Jay R McDonald
Journal:  Mayo Clin Proc       Date:  2010-03-15       Impact factor: 7.616

3.  Severe polyarthritis secondary to zolendronic acid: a case report and literature review.

Authors:  Sarah Louise White; Alyssa Jacob; Celia Gregson; Ashok Bhalla
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

4.  Bone-Targeted Extracellular Vesicles from Mesenchymal Stem Cells for Osteoporosis Therapy.

Authors:  Yayu Wang; Jie Yao; Lizhao Cai; Tong Liu; Xiaogang Wang; Ye Zhang; Zhiying Zhou; Tingwei Li; Minyi Liu; Renfa Lai; Xiangning Liu
Journal:  Int J Nanomedicine       Date:  2020-10-15

5.  Flare-up of hand osteoarthritis caused by zoledronic acid infusion.

Authors:  G R Werner de Castro; F S Neves; S C de Magalhães Souza Fialho; I A Pereira; G Ribeiro; A F Zimmermann
Journal:  Osteoporos Int       Date:  2009-11-21       Impact factor: 4.507

6.  Alendronate- and risedronate-induced acute polyarthritis.

Authors:  M Uğurlar
Journal:  Osteoporos Int       Date:  2016-07-04       Impact factor: 4.507

7.  Strontium ranelate improves post-extraction socket healing in rats submitted to the administration of bisphosphonates.

Authors:  Fernanda Castanheira Gonçalves; Bruno Arruda Mascaro; Cássio Rocha Scardueli; Guilherme José Pimentel Lopes de Oliveira; Luis Carlos Spolidorio; Rosemary Adriana Chierici Marcantonio
Journal:  Odontology       Date:  2022-01-18       Impact factor: 2.885

8.  Profound muscle weakness and pain after one dose of actonel.

Authors:  Irina Badayan; Merit E Cudkowicz
Journal:  Case Rep Med       Date:  2009-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.